Our Pipeline
Last updated, April 2021.
Molecule / Project
|
Indication
|
Expected Launch
|
Preclinical Phase | Phase I | Phase II | Phase III | Under Registration | Geography |
---|---|---|---|---|---|---|---|---|
Tirbanibulin | Actinic Keratosis | 2021 |
|
|||||
MC2-01 | Psoriasis | 2021 |
|
|||||
Lebrikizumab | Atopic dermatitis | 2023 |
|
|||||
Sarecycline | Acne | 2023 |
|
Programs in Research & Preclinical